Cooper Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$556K Sell
4,403
-1,339
-23% -$176K 0.05% 250
2026
Q1
$800K Buy
5,742
+1,015
+21% +$142K 0.08% 190
2025
Q4
$580K Buy
4,727
+607
+15% +$73.8K 0.06% 222
2025
Q3
$457K Buy
4,120
+1,517
+58% +$172K 0.05% 250
2025
Q2
$289K Buy
2,603
+261
+11% +$27.8K 0.03% 307
2025
Q1
$262K Buy
+2,342
New +$242K 0.03% 329
2024
Q3
Sell
-7,209
Closed -$495K 392
2024
Q2
$495K Buy
7,209
+4,463
+163% +$298K 0.07% 220
2024
Q1
$201K Sell
2,746
-291
-10% -$22.4K 0.03% 339
2023
Q4
$246K Buy
+3,037
New +$236K 0.04% 302
2023
Q2
Sell
-2,915
Closed -$242K 322
2023
Q1
$242K Buy
2,915
+543
+23% +$45K 0.07% 267
2022
Q4
$204K Buy
+2,372
New +$188K 0.06% 279
2020
Q3
Sell
-4,584
Closed -$353K 210
2020
Q2
$353K Buy
4,584
+80
+2% +$6.13K 0.11% 127
2020
Q1
$337K Buy
4,504
+308
+7% +$21.3K 0.14% 99
2019
Q4
$273K Buy
4,196
+195
+5% +$12.7K 0.11% 117
2019
Q3
$254K Buy
4,001
+397
+11% +$26K 0.11% 117
2019
Q2
$243K Buy
3,604
+149
+4% +$9.8K 0.12% 109
2019
Q1
$225K Buy
3,455
+211
+7% +$14K 0.12% 104
2018
Q4
$203K Buy
+3,244
New +$227K 0.14% 98

Other funds holding GILD

Cooper Financial Group's GILD Position: Q2 2026 in Review

Cooper Financial Group reduced its Gilead Sciences (GILD) stake by 23% in Q2 2026, selling an estimated $176K and leaving 4,403 shares worth $556K. The position accounts for 0.05% of the portfolio, ranked #250.

Cooper Financial Group first reported a position in GILD in Q4 2018 and has held it in 18 quarters since. The position peaked at $800K in Q1 2026. 328 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cooper Financial Group held 4,403 shares of Gilead Sciences worth $556K as of Q2 2026.
  • Cooper Financial Group sold 1,339 Gilead Sciences shares in Q2 2026, an estimated $176K.
  • Gilead Sciences made up 0.05% of Cooper Financial Group's portfolio in Q2 2026, its #250 holding.
  • Cooper Financial Group first reported a position in Gilead Sciences in Q4 2018 and has held it in 18 quarters since.
  • Cooper Financial Group's Gilead Sciences position peaked at $800K in Q1 2026.
  • 328 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cooper Financial Group's 13F filing for Q2 2026, filed 8 Jul 2026.